1. Zhao, Kai, Bai, Xuexue, Wang, Xiao, Li, Wei, Wang, Shiyong. 2023. Insight on the hub gene associated signatures and potential therapeutic agents in epilepsy and glioma. In Brain research bulletin, 199, 110666. doi:10.1016/j.brainresbull.2023.110666. https://pubmed.ncbi.nlm.nih.gov/37192718/
2. Xie, Meng, Xin, Chun. 2022. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis. In Biochemical and biophysical research communications, 610, 92-98. doi:10.1016/j.bbrc.2022.04.060. https://pubmed.ncbi.nlm.nih.gov/35461072/
3. Vitucci, Daniela, Di Giorgio, Annabella, Napolitano, Francesco, Bertolino, Alessandro, Usiello, Alessandro. 2015. Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 41, 916-27. doi:10.1038/npp.2015.228. https://pubmed.ncbi.nlm.nih.gov/26228524/
4. Seredenina, Tamara, Gokce, Ozgun, Luthi-Carter, Ruth. 2011. Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. In PloS one, 6, e22231. doi:10.1371/journal.pone.0022231. https://pubmed.ncbi.nlm.nih.gov/21779398/
5. Tan, Siyuan, Damodaran, Tirupapuliyur. 2024. Gene Expression Profiling and Immune Pathway Dysregulation in Ribonucleoprotein Autoantibody-Positive Systemic Lupus Erythematosus Patients. In Genes, 15, . doi:10.3390/genes15111353. https://pubmed.ncbi.nlm.nih.gov/39596553/
智鼠故事 
